Dupilumab for moderate-severe atopic dermatitis: a real-world, single-center retrospective study of 122 patients in the United States.
Veronica K EmmerichJosiah A WilliamsMatthew L HrinSteven R FeldmanLindsay C StrowdPublished in: International journal of dermatology (2023)